Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Spyre Therapeutics Inc (SYRE)

Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,193,706
  • Shares Outstanding, K 36,151
  • Annual Sales, $ 890 K
  • Annual Income, $ -338,790 K
  • 60-Month Beta 2.93
  • Price/Sales 1,397.08
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SYRE with:

Options Overview Details

View History
  • Implied Volatility 86.10% ( -0.71%)
  • Historical Volatility 63.37%
  • IV Percentile 42%
  • IV Rank 11.82%
  • IV High 106.32% on 04/10/24
  • IV Low 83.39% on 05/03/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 93
  • Open Int (30-Day) 130

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.90
  • Number of Estimates 2
  • High Estimate -0.85
  • Low Estimate -0.94
  • Prior Year -5.00
  • Growth Rate Est. (year over year) +82.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.27 +12.54%
on 04/25/24
40.83 -13.82%
on 04/12/24
-3.99 (-10.18%)
since 04/09/24
3-Month
20.07 +75.34%
on 02/22/24
47.97 -26.64%
on 03/18/24
+11.24 (+46.93%)
since 02/09/24
52-Week
2.66 +1,222.93%
on 06/21/23
47.97 -26.64%
on 03/18/24
+31.10 (+761.44%)
since 05/09/23

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Spyre Therapeutics is a biotechnology company which aims to create inflammatory bowel disease products by combining antibody engineering, rational therapeutic combinations and precision medicine approaches for patient selection. Spyre Therapeutics, formerly known as Aeglea BioTherapeutics Inc., is based...

See More

Key Turning Points

3rd Resistance Point 40.19
2nd Resistance Point 38.09
1st Resistance Point 36.64
Last Price 35.19
1st Support Level 33.10
2nd Support Level 31.00
3rd Support Level 29.55

See More

52-Week High 47.97
Last Price 35.19
Fibonacci 61.8% 30.66
Fibonacci 50% 25.32
Fibonacci 38.2% 19.97
52-Week Low 2.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar